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Perbandingan Antara “Automated Auditory Brainstem Response (AABR)” dan “Integrated 
Electrodes and Otoacoustic Emissions (OAEs)” Dalam Saringan Pendengaran Di Kalangan 
Bayi Yang Berisiko Tinggi di Hospital Universiti Sains Malaysia (HUSM) 
 
OBJEKTIF 
Untuk membandingkan keputusan saringan pendengaran menggunakan AABR ( melalui mesin 
MB11 BERAphone) dan “Integrated Electrodes dan Otoacoustic Emissions (OAEs)” di 
kalangan bayi yang berisiko tinggi dalam HUSM 
 
TATACARA 
Saringan pendengaran ini dilakukan dalam kajian keratan rentas. Seramai 195 bayi yang 
berisiko tinggi memenuhi kriteria- kriteria yang telah ditetapkan terlibat di dalam kajian ini. 
Bayi yang berisiko tinggi dalam masalah pendengaran diuji menggunakan mesin OAEs dan 
diikuti dengan mesin MB11 BERAphone di wad yang sama dan dilakukan setelah pesakit yang 
telah dirawat di wad disahkan sihat dan boleh didiscaj dari hospital. Kedua – dua mesin ini 
akan menghasilkan signal “lulus” atau “ rujuk” sebagai keputusan. Keputusan yang telah 






Keputusan yang dibuat oleh kedua – dua mesin ini sebagai “ rujuk” akan disaringkan sekali 
lagi dengan menggunakan mesin ABR untuk menentukan keputusan muktamad. Masa akan 
direkodkan semasa ujian saringan pendengaran oleh kedua – dua mesin tersebut bagi tujuan 
analisa. Bagi mengurangkan ketirisan semasa penggunaan kedua -dua mesin tersebut, kami 
menyediakan dua orang penganalisa yang akan membuat saringan ke atas pesakit. 
 
KEPUTUSAN 
Seramai 195 bayi (87, 44.6% adalah lelaki dan 108, 55.4% adalah perempuan) terlibat dalam 
kajian ini. Risiko kesan sampingan ubat adalah yang paling ramai (51.8%) diiringi dengan 
kesan penyakit kuning (51.3%) dan berat lahir < 1500g (27.2%). MB11 BERAphone 
mempunyai markah tertinggi bagi lulus ujian saringan pendengaran (89.8%) berbanding 
dengan OAEs sebanyak (85.2%). MB11 BERAphone mempunyai peratus yang sedikit bagi 
ujian saringan yang “rujuk” iaitu 10.2% berbanding OAEs adalah 14.8%. Ini menunjukkan 
perbezaan saringan pendengaran diantara kedua - dua ini adalah tercapai.  Bagi “true negative” 
untuk MB11 BERAphone adalah (29.4%) lebih tinggi berbanding OAEs iaitu (11.8%). “False 
negative” MB11 BERAphone adalah (5.9%) dan OAEs adalah (0.0%).  Daripada 195 bayi, 
seramai 182 (93.4%) bayi menunjukkan kesepakatan di antara kedua - dua mesin saringan 
pendengaran ini dan seramai 13 (6.6%) bayi tiada kesepakatan. Dari situ, sasaran kesepakatan 
tercapai (kappa = 0.698, p<0.001).  Ujian masa bagi saringan pendengaran yang telah dilakukan 
oleh kedua - dua mesin menunjukkan MB11 BERAphone adalah lebih kurang 5 minit (IQR: 
25th-75th) dan OAEs adalah lebih kurang 2 minit (IQR: 25th-75th). Ini menunjukkan perbezaan 






Kesimpulannya, saringan pendengaran menggunakan MB11 BERAphone adalah sesuai 
digunakan semasa ujian saringan di kalangan bayi –bayi yang berisiko tinggi. Walaupun 
terdapat keputusan “false negative” menggunakan MB11 BERAphone dan kemungkinan 
keputusan tersebut tidak tepat disebabkan beberapa faktor yang mempengaruhi keputusan 
tersebut. Terdapat kesepakatan di antara dua mesin tersebut. Walau bagaimanapun, masa yang 
diambil oleh MB11 BERAphone untuk membuat ujian saringan pendengaran setiap bayi 
mengambil masa yang agak lama berbanding dengan OAEs. Kami mencadangkan OAEs dan 
MB11 BERAphone boleh digunakan bagi peringkat pertama ujian saringan pendengaran, 
kemudian bayi boleh disaringkan sekali lagi melalui ABR sekiranya keputusan saringan 




















A Comparison of Automated Auditory Brainstem Response (AABR) with Integrated Electrodes 
and Otoacoustic Emissions (OAEs) in High Risk Newborn Hearing Screening in Hospital 
Universiti Sains Malaysia. 
  
OBJECTIVE  
To compare the outcome between AABR  (by using MB11 BERAphone method) and 
Integrated Electrodes and Otoacoustic Emissions (OAEs) in high risk newborn in Hospital 
Universiti Sains Malaysia. 
 
METHODS  
This is an observational study which is a cross-sectional study design involving two methods 
in the same subject.  A total of 195 high risk newborn and who have fulfilled the inclusion and 
exclusion criteria will be participate in our study. These high risk babies were subjected to 
OAEs and followed by an MB11 BERAphone screening test at the same setting as near to 
discharge as possible or once the patient is stable enough to do a hearing screening. Both 
instruments produced a “pass” or “refer” result and did not require any special skills for the 
interpretation of results. The “refer” result from OAEs and MB11 BERAphone will be screened 
using ABR to determine the false positive. The time will be measured by total staff time spent 
on each instrument. To minimise the measurement bias, two testers will be used to handle both 





There were 195 newborns (87, 44.6% boys and 108, 55.4% girls) who participated in this study. 
Ototoxic medication was the most common risk factor (51.8%) followed by 
hyperbilirubinaemia (51.3%), and birth weight <1500g (27.2%). MB11 BERAphone had a 
higher passing rate (89.8%) as compared to OAEs (85.2%). MB11 BERAphone had a lower 
refer rate (10.2%) compared to OAEs (14.8%). These differences are statistically significant. 
The true negatives are MB11 BERAphone (29.4%) and OAEs (11.8%). False negative MB11 
BERAphone (5.9%) and OAEs (0.0%). Out of 195 newborns examined, 182 (93.4%) showed 
agreement between the two techniques, whereas in 13 (6.6%) there was no agreement. Inter-
observer agreement was good (kappa = 0.698, p=<0.001). The median test time that was done 
for each newborn using MB11 BERAphone was 5 minutes (IQR: 25th-75th) and OAEs was 2 
minutes (IQR: 25th-75th). The difference were statistically significant (p = <0.001). 
 
CONCLUSION  
The MB11 BERAphone is still a reliable device for auditory brainstem response among high 
risk newborn hearing screening. In the presence of false negative in MB11 BERAphone, it 
might not really be significant in this study due to a few factors affecting the result. Both 
agreements were good. However, the duration of time for hearing screening for each newborn 
took a significantly longer time compared to OAEs. Therefore, we recommend that both 
methods can be used as a first screening, followed by a screening using ABR for those whose 




































Hearing is the ability to perceive sound by detecting vibrations. Hearing is performed 
primarily by the auditory system in which mechanical waves, known as vibrations are detected 
by the ear and transduced into nerve impulses that are perceived by the brain (primarily in the 
temporal lobe). Hearing loss is a partial or total inability to hear. Hearing loss may occur in one 
or both ears. In children hearing, problems can affect the ability to learn spoken language later 
on when they grow. So it is important to detect earlier which of these babies are on the high 
risk of hearing impairment.1 
Early diagnosis and intervention are necessary for social and linguistic development in 
children with congenital hearing loss. The Universal Newborn Hearing Screening (UNHS) has 
proven beneficial in detecting hearing impairment shortly after birth and with adequate 
habilitation, it gives the child a better chance of normal development. Many techniques are 
used for the evaluation of hearing sensitivity and among them we have Integrated Electrodes 
Otoacoustic Emissions (OAEs) and also automated auditory brainstem response (AABR).2 
Otoacoustic emissions (OAEs) hearing screening is used widely in hospital-based 
newborn hearing screening programs. Otoacoustic emissions (OAEs) screening can help to 
detect sensorineural hearing loss occurring in the cochlea. It can also call attention to hearing 
disorders affecting the pathway to the inner ear. The procedure is performed with a portable 
handheld screening unit. A small probe is placed in the child's ear canal. This probe delivers a 
low-volume sound stimulus into the ear. The cochlea responds by producing an otoacoustic 
emission, sometimes described as an “echo,” that travels back through the middle ear to the ear 
canal and is analysed by the screening unit. The otoacoustic emissions (OAEs) screening 
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performed by White et al (1993) on 1,850 neonates showed a sensitivity of around 100% and 
a specificity of 73%.1 
The automated auditory brainstem response (AABR) screener is a dedicated hearing 
screening device which provides information not only about the outer/middle ear and cochlea 
but also about the auditory pathway up to the brainstem. AABR screening is highly sensitive. 
The screening is based on the measurement of synchronous activity in the auditory nerve up to 
the colliculus inferior in the brainstem as a reaction to click stimuli delivered to the ears. It is 
useful in infants at risk of hearing impairment, including those admitted to a Neonatal Intensive 
Care Unit (NICU). 
MB11 BERAphone is one of the automated auditory brainstem response (AABR). The 
MB11 BERAphone is a more recently developed hearing screening device. MB11 
BERAPhone is the only automatic ABR screener without adhesive electrodes. The click 
stimulus used simultaneously reaches cochlear areas generating a more robust and faster 
auditory response compared to normal AABR clicks. The MB11 BERAphone test showed very 
good specificity 96.8% and sensitivity 100%.3 
Auditory Brainstem Response (ABR) is the gold standard test, which is essential to a 
correct neonatal screening programme both in patients not passing the test with otoacoustic 
emissions (OAEs) and automated auditory brainstem response (AABR). The auditory 
brainstem response (ABR) reflects the function of the entire auditory pathway up to the 
brainstem. While both ABR and the alternate screening technology of otoacoustic emissions 




However, it has some drawbacks such as high cost, difficult instrument transportation, 
long execution time, and a need for qualified personnel to interpret the ABR. This study is 
conducted due to there being only a few research studies done about the comparison of MB11 
BERAphone with OAEs. So far, there is no research study done in Malaysia comparing both 



















































2. LITERATURE REVIEW  
2.1 UNIVERSAL NEONATAL HEARING SCREENING  
 The ear is one of the important parts of the body in which to function as hearing. 
Hearing is one indicator for a baby to grow as a normal child in terms of cognitive development, 
as well as neurodevelopment. Early neonatal hearing screening was developed all over the 
world to prevent late detection of hearing impairment. Thus, hearing screening was done during 
the neonatal period. Hearing loss may have significant adverse effects on the development of 
speech, language capabilities and social - emotional development, as well as leading to 
worsening educational and occupational performance in adulthood. Regular physical 
examinations cannot detect hearing loss, so neonatal hearing screening (NHS) is necessary. 
Hearing loss may be sensorineural or conductive, permanent or transient, unilateral or bilateral 
and of varying severity. Infants with moderate or worse (>40 dB) bilateral sensorineural 
hearing loss (SNHL) have heightened risk of poor speech and language development outcomes 
if hearing augmentation/intervention programs are not implemented promptly.4 
 The incidence of permanent hearing impairment in newborns ranges between 1.0% and 
5.5% across regions and countries.5 Many studies have illustrated the validity and reliability of 
Universal Neonatal Hearing Screening (UNHS) programs in the early detection of newborn 
hearing impairment. More importantly, newborns with hearing loss that is detected early can 
receive intervention before 6 months of age, which is critical in allowing them to develop 
linguistic, cognitive and logical abilities on par with normal infants. Because of their feasibility 
and effectiveness, Universal Neonatal Hearing Screening (UNHS) programs have been 
implemented in many countries all over the world; its coverage rate is one of the most important 




2.2 NEONATAL HEARING SCREENING AMONG HIGH RISK NEWBORN 
In most countries, newborn hearing screening programmes that screen only high-risk 
infants have been in existence for more than 20 years. However, this group of infants with 
hearing loss comprises only 50% of newborn population with hearing loss. Therefore, hearing 
screening programs that screened only high-risk neonates missed out 50% of hearing impaired 
newborns, who are from among infants without any risks factors. The prevalence of hearing 
loss is estimated to be between 2.5% and 10% among high-risk infants.1  
The risk factors of hearing loss in neonates were first documented in 1994 and then 
revised in 2000 by the Joint Committee on Infant Hearing (JCIH). The newborn high risk group 
included infants who had asphyxia (low APGAR score, 0–4 at 1 minutes or 0-6 at 5 minutes), 
meningitis, congenital or perinatal infections, anatomic defects or stigmata, hyper 
bilirubinemia, a family history of hearing loss, low birth weight, ototoxic medications, 
syndromes known to be associated with hearing loss and neonatal illnesses requiring 
mechanical ventilation.6’
7 Other risk factors have been tested, such as maternal drug abuse, 
persistent high pulmonary pressure, intra-ventricular haemorrhage, high C reactive protein 
levels but were not proven to be significant.7  
High risk newborns can be divided into congenital and acquired hearing loss. Mostly, 
they have hearing impairment at birth and are potentially identifiable by newborn and infant 
hearing screening. The risk factors for congenital hearing loss such as craniofacial anomalies, 
syndromes related with hearing loss, a family history of hearing loss, premature baby and in 
utero infection. However, some congenital hearing loss may not become evident until later in 
childhood. Hearing impairment can also be acquired during neonatal or infancy period for 
various reasons. Examples of babies who are at high risk of acquired hearing loss are those 
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who suffer from such conditions such as meningitis, otitis media, mechanical ventilation, hyper 
bilirubinaemia and ototoxic medications.8 
 
2.3 SCREENING TEST AND EQUIPMENT   
The ideal screening test would have a high sensitivity and a high specificity. A high 
sensitivity is particularly important to enable catching up on all infants with significant hearing 
loss without a delay in the diagnosis of hearing impairment. A high specificity is required, as 
a false positive result could lead to much workload on the diagnostic services (over referrals) 
and undue parental anxiety.6 Two objective methods were used in most universal hearing-
screening programs. They are automated otoacoustic emissions (OAEs) and automated ABR 
(AABR). They are available as handheld portable equipment with a pass or fail criterion. In 
this study, we are using MB11 BERAphone as an AABR and comparing it with otoacoustic 
emissions (OAEs). The Auditory Brainstem Response (ABR) is still the gold standard test, 
which is essential to correct neonatal screening programme both in patients not passing the test 
with otoacoustic emissions (OAEs) and automated auditory brainstem response (AABR), 
MB11 BERAphone.9 
 
2.3.1 Integrated Electrodes and Otoacoustic Emissions (OAEs) 
OAEs are used to assess cochlear integrity and are physiologic measurements of the 
response of the outer hair cells to acoustic stimuli. They serve as a fast objective screening test 
for normal preneural cochlear function through the use of probe in the ear canal.6 The presence 
of normal responses in an OAEs test is a strong predictor of a full hearing function. The 
procedure of OAEs suppression allows for a functional investigation of the efferent 
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olivocochlear system, which plays an important role in auditory information processing.10 The 
sensitivity and speciﬁcity of the OAEs were found to be 90% and 92.4% when compared to 
ABR results and 90.9% and 91.1% when compared to the children’s hearing status, 
respectively.11 
Currently, two types of evoked OAEs measurements are used for newborn hearing 
screening, transient evoked otoacoustic emissions (TEOAEs) and distortion product 
otoacoustic emissions (DPOAEs). DPOAEs measurements are better suited to advanced 
clinical investigation on adult patients, even though DPOAEs analysis is complex and 
interpretation is difficult. The distortion product (DP) technique is more flexible and potentially 
more powerful than TEOAEs analysis, having a wider useful frequency range. Waveform 
based TEOAEs measurements, as originally used in universal newborn hearing screening 
programmes, are also useful as a sensitive initial screen prior to full clinical examination. 
TEOAEs are also more sensitive to cochlear status changes manifested in subtle changes in the 
TEOAEs waveform. DPOAEs instruments can be used for screening with an appropriately low 











Figure 2.1: (A) TEOAEs probe containing miniature sound source and microphone 
transducers. The soft disposable tip carries sound ports for the stimulus and for the microphone. 
DPOAEs probes have an additional stimulus port. In some probes, all ports feed a single sound 
tube. (B) The probe needs to be deeply inserted in the ear canal for maximum OAEs capture 
and noise exclusion, with the cable positioned so as to avoid noise production on movement.13 
 
2.3.2 MBII BERAphone  
As we know there are two methods commonly used in universal newborn hearing 
screening: Otoacoustic emissions (OAEs) and automated auditory brainstem 
response (AABR), both methods being automated. AABR is superior to OAEs, among the 
screening tests, because the AABR will be able to identify retrocochlear hearing impairments, 
such as auditory neuropathy which are missed out on OAEs screening. The AABR test uses a 
series of click sounds at 35 dB hearing level and detects brainstem responses to these stimuli. 
AABR has also been found to be time and cost effective, with a high sensitivity and a low 
failure rate.14  
A B 
